Urinary Tract Infection clinical trials at UCSF
2 in progress, 0 open to eligible people
Antibiotics for Kidney Transplant Recipients
Sorry, not yet accepting patients
The goal of this clinical trial is to learn if a common antibiotic called trimethoprim-sulfamethoxazole (TMP-SMX) can help prevent urinary tract infections (UTIs) in children and young adults who recently had a kidney transplant. Most people take TMP-SMX for about 6 months after getting a kidney transplant. In this study, researchers want to see what happens if people keep taking it for 6 more months. The main questions this study is asking are: - Does TMP-SMX lower the number of UTIs in the first year after transplant? - What side effects or problems do participants have while taking TMP-SMX? Researchers will compare TMP-SMX to a placebo (a look-alike pill that does not contain any medication) to see if TMP-SMX works to prevent UTIs. Participants will: - Take either TMP-SMX or a placebo pill by mouth every day for 6 months - Have three visits to touch base with the study team about any issues - Complete short monthly online surveys about any symptoms or side effects - Share blood and urine test results from their regular transplant clinic visits
San Francisco, California
Preoperative Prophylactic Antibiotic Duration in Moderate to High Risk Ureteroscopy
Sorry, not yet accepting patients
The goal of this non-inferiority randomized controlled trial: is to test the hypothesis that the that there is no additional benefit from a longer course (7 days) versus a shorter course (2 days) of pre-operative antibiotics in patients with moderate to high risk of infection undergoing ureteroscopy. The main questions it aims to answer are: 1. Determine the safety and efficacy of a short course (2 days) as compared to a long course (7 days) 2. Identify secondary predictors of post-operative infectious complications
San Francisco, California
Our lead scientists for Urinary Tract Infection research studies include Alexandra Bicki, MD.
Last updated: